Skip to content
Meclocycline sulfosalicylate
Meclan (meclocycline sulfosalicylate) is a small molecule pharmaceutical. Meclocycline sulfosalicylate was first approved as Meclan on 1982-01-01.
Download report
Favorite
Commercial
Therapeutic Areas
No data
Trade Name
FDA
EMA
No data
Drug Products
FDA
EMA
New Drug Application (NDA)
New Drug Application (NDA)
Abbreviated New Drug Application (ANDA)
Abbreviated New Drug Application (ANDA)
Meclocycline sulfosalicylate
Tradename
Company
Number
Date
Products
MECLANJohnson & JohnsonN-050518 DISCN1982-01-01
1 products
Hide discontinued
Labels
FDA
EMA
No data
Indications
FDA
EMA
No data
Agency Specific
FDA
EMA
No data
Patent Expiration
No data
ATC Codes
No data
HCPCS
No data
Clinical
Indications Phases 4
No data
Indications Phases 3
No data
Indications Phases 2
No data
Indications Phases 1
No data
Indications Without Phase
No data
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
General
Drug common nameMECLOCYCLINE SULFOSALICYLATE
INN—
Description
Meclan (meclocycline sulfosalicylate) is a small molecule pharmaceutical. Meclocycline sulfosalicylate was first approved as Meclan on 1982-01-01.
Classification
Small molecule
Drug classantibiotics (tetracycline derivatives); phosphoro-derivatives; anti-inflammatory agents (salicylic acid derivatives)
Image (chem structure or protein)
Structure (InChI/SMILES or Protein Sequence)
C=C1c2c(Cl)ccc(O)c2C(=O)C2=C(O)[C@]3(O)C(=O)C(C(N)=O)=C(O)[C@@H](N(C)C)[C@@H]3[C@@H](O)[C@H]12.O=C(O)c1cc(S(=O)(=O)O)ccc1O
Identifiers
PDB—
CAS-ID73816-42-9
RxCUI—
ChEMBL IDCHEMBL261772
ChEBI ID—
PubChem CID54676538
DrugBank—
UNII ID—
Target
Agency Approved
No data
Alternate
No data
Variants
Clinical Variant
No data
Financial
No data
Trends
PubMed Central
Top Terms for Disease or Syndrome:
Mock data
Subscribe for the real data
Additional graphs summarizing 20 documents
View more details
Safety
Black-box Warning
No Black-box warning
Adverse Events
Top Adverse Reactions
0 adverse events reported
View more details